Scientific Opinion on the substantiation of a health claim related to Bifidobacterium bifidum CNCM I‐3426 and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Scientific Opinion on the substantiation of a health claim related to Bifidobacterium bifidum CNCM I‐3426 and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Abstract Following an application from Lallemand Health Solutions, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation...

Full description

Bibliographic Details
Main Author:	EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Format:	Article
Language:	English
Published:	Wiley 2015-05-01
Series:	EFSA Journal
Subjects:	Bifidobacterium bifidum CNCM I‐3426 defence against pathogens immune function upper respiratory tract health claim
Online Access:	https://doi.org/10.2903/j.efsa.2015.4094

Similar Items

Scientific Opinion on the substantiation of a health claim related to a combination of <em>Lactobacillus helveticus</em> CNCM I-1722, <em>Bifidobacterium longum</em> subsp. <em>infantis</em> CNCM I-3424, <em>Bifidobacterium bifidum</em> CNCM I 3426 and fructo oligosaccharides from sucrose and contribution to immune defence against pathogens (ID 3016, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens (ID 931, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I‐1720 and Lactobacillus helveticus CNCM I‐1722 and defence against pathogenic gastro‐intestinal microorganisms (ID 939, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus rhamnosus</em> CNCM I-1720, <em>Lactobacillus helveticus</em> CNCM I-1722, <em>Bifidobacterium longum</em> subsp. <em>longum</em> CNCM I-3470 and <em>Saccharomyces cerevisiae</em> var. <em>boulardii</em> CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms (ID 3017, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus helveticus</em> CNCM I-1722 and <em>Bifidobacterium longum</em> subsp. <em>longum</em> CNCM I-3470 and alleviation of psychological stress (ID 938) and “maintains the balance of healthy microbiota that helps to strengthen the natural defence” (ID 2942) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Scientific Opinion on the substantiation of health claims related to Lactobacillus casei DG CNCM I‐1572 and decreasing potentially pathogenic gastro intestinal microorganisms (ID 2949, 3061, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Scientific Opinion on the substantiation of health claims related to Saccharomyces cerevisiae var. boulardii CNCM I‐1079 and defence against pathogenic gastro‐intestinal microorganisms (ID 913, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Efficacy of Bifidobacterium Infantis versus Bifidobacterium Bifidum Probiotic in the Prevention of Necrotizing Enterocolitis in Preterm Neonates
by: Sidra Tul Muntaha
Published: (2016-12-01)

The Effect of Feeding Neutralizer on the Growth of Bifidobacterium Bifidum
by: Shu Guowei, et al.
Published: (2015-07-01)

Scientific Opinion on the substantiation of a health claim related to <em>Saccharomyces cerevisiae</em> var. <em>boulardii</em> CNCM I-3799 and reducing gastro-intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-07-01)

Scientific Opinion on the substantiation of health claims related to a combination of <em>Lactobacillus paracasei</em> CNCM I-1688 and <em>Lactobacillus salivarius</em> CNCM I-1794 and reduction of gastro-intestinal discomfort (ID 2972), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL-10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Bifidobacterium bifidum as an example of a specialized human gut commensal
by: Francesca eTurroni, et al.
Published: (2014-08-01)

2′-Fucosyllactose as a prebiotic modulates the probiotic responses of Bifidobacterium bifidum
by: Jingfang Du, et al.
Published: (2025-01-01)

Optimization of nitrogen source for Bifidobacterium bifidum using response surface methodology
by: Chen He, et al.
Published: (2016-06-01)

Administration of lactobacillus casei and bifidobacterium bifidum ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats
by: Poonam Sharma, et al.
Published: (2016-01-01)

Bifidobacterium bifidum postbiotics prevent Salmonella Pullorum infection in chickens by modulating pyroptosis and enhancing gut health
by: Yuhao Chen, et al.
Published: (2025-04-01)

Genome Analysis of <i>Bifidobacterium Bifidum</i> E3, Structural Characteristics, and Antioxidant Properties of Exopolysaccharides
by: Yingxue Yue, et al.
Published: (2023-08-01)

Application of central composite design to optimize the amount of carbon source and prebiotics for Bifidobacterium bifidum BB01
by: Shu Guowei, et al.
Published: (2016-06-01)

<i>Bifidobacterium bifidum</i>: A Key Member of the Early Human Gut Microbiota
by: Francesca Turroni, et al.
Published: (2019-11-01)

The Effect of Echium amoenum Hydro-alcoholic Extract on the Growth of Probiotic Bacteria Lactobacillus Acidophilus and Bifidobacterium Bifidum in Kefir
by: Khadijeh Zarei, et al.
Published: (2020-04-01)

Bifidobacterium bifidum-Mediated Specific Delivery of Nanoparticles for Tumor Therapy
by: Tang Y, et al.
Published: (2021-07-01)

Optimization the Process of Microencapsulation of Bifidobacterium bifidum BB01 by Box-Behnken Design
by: Chen He, et al.
Published: (2016-12-01)

Effect of Microencapsulation on Survival and Stability of Bifidobacterium bifidum BB01 Exposed to Simulated Gastrointestinal Conditions and in Different Food Matrices
by: Chen He, et al.
Published: (2017-06-01)

Effects of Sugars, Alcohols and Antioxidants on the Preparation Goat Milk Tablets Containing Bifidobacterium bifidum BB01
by: Li Ting, et al.
Published: (2023-12-01)

Evaluating the Effect of Supernatant Collected from the Culture of Bifidobacterium bifidum on the Increase of Angiogenesis in Acute Wound Healing
by: Pegah Moussavi amin, et al.
Published: (2021-09-01)

Effect of Sodium Tripolyphosphate, Glycerol, Vitamin B2, Mannitol and Solid Malt Extract on Survival of Bifidobacterium bifidum During Freeze-Drying
by: Shu Guowei, et al.
Published: (2019-06-01)

Scientific Opinion on the substantiation of health claims related to various microorganisms and reduction of gastro-intestinal discomfort (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), improved lactose digestion (ID 1030, 2956, 2958, 2961, 2963, 2966, 2970), “intestinal flora/digestive health” (ID 4231), defence against vaginal pathogens (ID 2950, 2957, 2967) and increasing IL-10 production and/or enhancing the activity of natural killer cells (ID 2960, 2962, 2971) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Enhancement of Innate Immune Function in Mice by Bifidobacterium bifidum FL-228.1
by: Yu ZHOU, et al.
Published: (2023-11-01)

Production of biologically active human interleukin-10 by Bifidobacterium bifidum BGN4
by: Nayoun Hong, et al.
Published: (2021-01-01)

Scientific Opinion on the substantiation of a health claim related to <em>Bifidobacterium animalis</em> subsp. <em>lactis</em> LMG P-21384 and changes in bowel function (ID 2940, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies
Published: (2012-08-01)

Bifidobacterium bifidum Suppresses Gut Inflammation Caused by Repeated Antibiotic Disturbance Without Recovering Gut Microbiome Diversity in Mice
by: Miriam N. Ojima, et al.
Published: (2020-06-01)

Viabilitas Dan Aktivitas Antibakteri Bifidobacterium bifidum Dalam Susu Bifidus Dengan Suplementasi Ekstrak Cengkeh (Syzygium aromaticum)
by: Nosa Septiana Anindita, et al.
Published: (2021-08-01)

Proteomic profiling of Bifidobacterium bifidum S17 cultivated under in vitro conditions
by: Xiao eWei, et al.
Published: (2016-02-01)

Scientific Opinion on the substantiation of a health claim related to a combination of <em>Bifidobacterium longum</em> LA 101, <em>Lactobacillus helveticus</em> LA 102, <em>Lactococcus lactis</em> LA 103 and <em>Streptococcus thermophillus</em> LA 104 and reducing intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2013-02-01)

Scientific Opinion on the substantiation of a health claim related to a combination of <em>Bifidobacterium longum</em> LA 101, <em>Lactobacillus helveticus</em> LA 102, <em>Lactococcus lactis</em> LA 103 and <em>Streptococcus thermophilus</em> LA 104 and reducing intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2014-05-01)

Scientific Opinion on the substantiation of a health claim related to a combination of <em>Bifidobacterium longum</em> LA 101, <em>Lactobacillus helveticus</em> LA 102, <em>Lactococcus lactis</em> LA 103 and <em>Streptococcus thermophilus</em> LA 104 and improves stool frequency pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2013-02-01)

Metabiotic extracted from Bifidobacterium bifidum modulates antioxidant capacity and inflammatory responses during peptic ulcer healing in male wistar rats: a preliminary study
by: Rika Almasyan, et al.
Published: (2023-02-01)

Preparation of a Whey-Based Probiotic Product with Lactobacillus reuteri and Bifidobacterium bifidum
by: Adrian Hernandez-Mendoza, et al.
Published: (2007-01-01)

Development of Chitosan-Polyacrylic Acid Complex Systems for Enhanced Oral Delivery of Lactobacillus Gasseri and Bifidobacterium Bifidum Probiotics
by: AL-Fawares O, et al.
Published: (2025-01-01)

Response Surface Optimization of Lyoprotectant from Amino Acids and Salts for Bifidobacterium Bifidum During Vacuum Freeze-Drying
by: Qi Kangru, et al.
Published: (2017-12-01)